Biotech Acquisition Co Alpha and Beta Analysis
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biotech Acquisition Co. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biotech Acquisition over a specified time horizon. Remember, high Biotech Acquisition's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biotech Acquisition's market risk premium analysis include:
Beta 0.0631 | Alpha (0.01) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biotech |
Biotech Acquisition Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biotech Acquisition market risk premium is the additional return an investor will receive from holding Biotech Acquisition long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotech Acquisition. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biotech Acquisition's performance over market.| α | -0.01 | β | 0.06 |
Biotech Acquisition Fundamentals Vs Peers
Comparing Biotech Acquisition's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biotech Acquisition's direct or indirect competition across all of the common fundamentals between Biotech Acquisition and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biotech Acquisition or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biotech Acquisition's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biotech Acquisition by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biotech Acquisition to competition |
| Fundamentals | Biotech Acquisition | Peer Average |
| Return On Asset | -0.0085 | -0.14 |
| Current Valuation | 290.09 M | 16.62 B |
| Shares Outstanding | 23 M | 571.82 M |
| Shares Owned By Institutions | 100.00 % | 39.21 % |
| Number Of Shares Shorted | 9.3 K | 4.71 M |
| Price To Earning | 29.21 X | 28.72 X |
| Price To Book | 1.33 X | 9.51 X |
Biotech Acquisition Opportunities
Biotech Acquisition Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Houston biotech FibroBiologics turns to online crowdfunding after ... - The Business Journals | 02/01/2023 |
2 | Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of... | 02/02/2023 |
About Biotech Acquisition Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biotech or other delisted stocks. Alpha measures the amount that position in Biotech Acquisition has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotech Acquisition in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotech Acquisition's short interest history, or implied volatility extrapolated from Biotech Acquisition options trading.
Build Portfolio with Biotech Acquisition
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |